The live price of Injective is ر.س per (INJ / SAR) with a current market cap of ر.س . 24-hour trading volume is $ SAR. INJ to USD price is updated in real-time. Injective is in the last 24 hours with a circulating supply of .
INJ is the main token on the Injective blockchain. You use it to pay fees, bid in the Burn Auction, stake to secure the network, and get involved in community governance to help shape the platform. It powers the whole ecosystem, driving growth and development in Web3 finance.
Injective uses a Proof-of-Stake (PoS) model with a custom version of the Tendermint framework. To keep things secure, nodes stake INJ tokens to help validate transactions and add new blocks to the chain. Validators and delegates earn rewards in INJ for their participation in the network.
Injective Labs was co-founded by Eric Chen and Albert Chon in 2018. It started as a DEX protocol for perpetual swaps, futures, and spot trading, but has grown into a Layer-1 blockchain designed for financial applications.
INJ has a max supply of 100 million tokens, and it was fully unlocked as of January 2024. Right now, about 98.85 million INJ are in circulation.
Injective stands out because it's built for DeFi with special modules and fast infrastructure that let developers create complex, high-performance apps easily. It's super scalable, handling over 25,000 transactions per second, with block times under a second and near-instant finality, all for just $0.0003 per transaction. Plus, its INJ token economy is designed for long-term growth, using a unique Burn Auction and supply system that scales with the ecosystem instead of getting bogged down by network congestion.
You can buy INJ directly on EXMON using a debit or credit card. If you prefer, you can also trade other cryptos for INJ on the exchange. The live price of Injective is updated in real-time on EXMON, and if you need more details, check out their "How to Buy Injective (INJ)" guide.
If you're wondering about the future price of INJ, check out the Injective Price Prediction page. Just keep in mind, the data there is based on user input, not EXMON's opinion. Always do your own research before setting any targets!
We may use cookies or any other tracking technologies when you visit our website, including any other media form, mobile website, or mobile application related or connected to help customize the Site and improve your experience. learn more